olpadronic acid has been researched along with Pain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hamdy, NA; Lycklama à Nijeholt, AA; Papapoulos, SE; Pelger, RC; Zwinderman, AH | 1 |
| Arndt, JW; Hamdy, NA; Lycklama à Nijeholt, GA; Papapoulos, SE; Pelger, RC; Soerdjbalie-Maikoe, V; Zwinderman, AH | 1 |
1 trial(s) available for olpadronic acid and Pain
| Article | Year |
|---|---|
Effects of the bisphosphonate olpadronate in patients with carcinoma of the prostate metastatic to the skeleton.
Topics: Administration, Oral; Aged; Aged, 80 and over; Alkaline Phosphatase; Antineoplastic Agents; Bone Neoplasms; Bone Resorption; Calcium; Diphosphonates; Follow-Up Studies; Humans; Hydroxyproline; Injections, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Osteoblasts; Pain; Prostatic Neoplasms | 1998 |
1 other study(ies) available for olpadronic acid and Pain
| Article | Year |
|---|---|
Strontium-89 (Metastron) and the bisphosphonate olpadronate reduce the incidence of spinal cord compression in patients with hormone-refractory prostate cancer metastatic to the skeleton.
Topics: Aged; Combined Modality Therapy; Diphosphonates; Humans; Lumbar Vertebrae; Male; Pain; Palliative Care; Prostatic Neoplasms; Retrospective Studies; Spinal Cord Compression; Spinal Neoplasms; Strontium; Thoracic Vertebrae; Treatment Outcome | 2002 |